{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-23-001188","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2023-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.186771+00:00","generated_at":"2026-06-14T14:28:22.375754+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AXIM Biotechnologies appoints Kurt Phinney as COO; grants option for 2M shares","bullets":["Kurt Phinney appointed COO effective May 23, 2023; minimum six-month term.","Compensation: option to buy up to 2,000,000 shares (S-8), vesting 1/6 every 30 days.","Phinney's prior roles include VP Ops at Lumos Diagnostics and Versea Health.","Consulting agreement with Accalle, LLC (Phinney's entity); no cash salary.","Agreement may be terminated after initial term with 30 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-23-001188","json":"https://secwatch.observer/filing/0001096906-23-001188.json","markdown":"https://secwatch.observer/filing/0001096906-23-001188.md","text":"https://secwatch.observer/filing/0001096906-23-001188.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/0001096906-23-001188-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/axim-20230523.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T14:28:22.375754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b2ae3fc246","claim":"Kurt Phinney was appointed as Chief Operating Officer at AXIM BIOTECHNOLOGIES, INC..","evidence_excerpt":"On May 23, 2023, our Chief Executive Officer appointed Kurt Phinney as the Company’s Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623001188/0001096906-23-001188-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}